Compare Stocks

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Belgravia Capital International Inc. focuses on incubation, investments, and royalty and management services businesses. The company offers capital to support the development of early stage companies in the biotech/healthcare, technology, resources, and medical sectors, as well as to support the international expansion on a selective basis. It also invests in various private and public companies with a focus on value; and provides merchant banking services. The company was formerly known as IC Potash Corp. and changed its name to Belgravia Capital International Inc. in November 2017. Belgravia Capital International Inc. is based in Toronto, Canada.

Danakali Limited, together with its subsidiaries, engages in the exploration of minerals in Eritrea, East Africa. The company focuses on the development of the Colluli potash project located in the Danakil Depression region of Eritrea. The company was formerly known as South Boulder Mines Ltd. and changed its name to Danakali Limited in June 2015. Danakali Limited was incorporated in 2001 and is based in North Perth, Australia.

Vegalab, Inc. primarily engages in the citrus packing business. The company operates in two segments, the Agronomy Business and the Packing Business. It also distributes biological pesticides, natural fertilizers, and specialty biological agents under the Vegalab brand name. The company markets its products through stocking distributors. It primarily operates in the United States. The company was formerly known as HPC Acquisitions, Inc. and changed its name to Vegalab, Inc. in November 2017. Vegalab, Inc. was founded in 1968 and is based in North Palm Beach, Florida.